1.34BMarket Cap-62.47P/E (TTM)
9.685High9.220Low1.28MVolume9.650Open9.690Pre Close11.97MTurnover0.97%Turnover RatioLossP/E (Static)143.18MShares10.67052wk High3.46P/B1.23BFloat Cap4.71052wk Low--Dividend TTM131.70MShs Float33.972Historical High--Div YieldTTM4.80%Amplitude1.000Historical Low9.350Avg Price1Lot Size
Aurinia Pharmaceuticals Stock Forum
Larger Image: tradingview.com...
$Aurinia Pharmaceuticals (AUPH.US)$
Larger Image: tradingview.com...
$Aurinia Pharmaceuticals (AUPH.US)$
Aurinia Presents New Data Highlighting Real-World Utilization and Value of LUPKYNIS® in Treating Lupus Nephritis at American Society of Nephrology Kidney Week 2024
Aurinia Pharmaceuticals Inc. (NASDAQ: AUPH) announced the acceptance of six abstracts at the American Society of Nephrology (ASN) Kidney Week 2024. The data reinforces the clinical importance of LUPKYNIS® (voclosporin) for treating adults with active lupus nephritis (LN). Key highlights include:
...
Larger Image: tradingview.com...
$Aurinia Pharmaceuticals (AUPH.US)$
Larger Image: tradingview.com...
$Aurinia Pharmaceuticals (AUPH.US)$
No comment yet